Genetic Engineering Publications - GEG Tech top picks
36.6K views | +0 today
Follow
Genetic Engineering Publications - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

CHO cells knocked out for TSC2 display an improved productivity of antibodies under fed batch conditions

CHO cells knocked out for TSC2 display an improved productivity of antibodies under fed batch conditions | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this work, the scientists used CRISPR/Cas9 editing to modify CHO cells to enforce high mTORC1 activity by knocking-out TSC2, a major mTOR inhibitory protein, or PTEN, a phosphatase that attenuates the PI3K/AKT/mTOR pathway. These data underscore manipulation of TSC as a strategy to improve performance of CHO cell in bioreactors.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

CRISPR-Cas targeted plasmid integration into mammalian cells via non-homologous end joining

CRISPR-Cas targeted plasmid integration into mammalian cells via non-homologous end joining | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this study, the authors show that a site specific double strand break (DSB) generated both in the genome and the donor plasmid using the CRISPR-Cas9 system can be efficiently used to target ∼5 kb plasmids into mammalian genomes via nonhomologous end joining (NHEJ). They were able to achieve efficiencies of up to 0.17% in HEK293 cells and 0.45% in CHO cells.


www.geg-tech.com/Vectors

Dominique Blanchard's comment, May 13, 2015 8:46 AM
I'm going to read this paper because It will greatly impact owners of homologous recombination related patents.
Scooped by BigField GEG Tech
Scoop.it!

CRISPR/Cas9‐mediated genome engineering of CHO cell factories: Application and perspectives

CRISPR/Cas9‐mediated genome engineering of CHO cell factories: Application and perspectives | Genetic Engineering Publications - GEG Tech top picks | Scoop.it



BigField GEG Tech's insight:

Chinese hamster ovary (CHO) cells are the most widely used production host for therapeutic proteins. With the recent emergence of CHO genome sequences, CHO cell line engineering has taken on a new aspect through targeted genome editing.


www.geg-tech.com/Vectors